Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Statin Intolerance in Patients With Myocardial Infarction

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04069598
Recruitment Status : Recruiting
First Posted : August 28, 2019
Last Update Posted : September 12, 2019
Sponsor:
Information provided by (Responsible Party):
Turkish Society of Cardiology

Brief Summary:
Patients with acute coronary syndrome (MI, NSTEMI, USAP) will be included. They will be screened for statin intolernace for 6 months.

Condition or disease Intervention/treatment
Statin Adverse Reaction Diagnostic Test: Statin intolerance test

Layout table for study information
Study Type : Observational
Estimated Enrollment : 600 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Statin Intolerance in Patients With Myocardial Infarction
Actual Study Start Date : August 26, 2019
Estimated Primary Completion Date : March 2, 2020
Estimated Study Completion Date : March 31, 2020

Resource links provided by the National Library of Medicine



Intervention Details:
  • Diagnostic Test: Statin intolerance test
    Statin intolerance test


Primary Outcome Measures :
  1. Statin intolerance [ Time Frame: 6 months ]
    Number (percentage) of patients with statin intolerance



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Acute coronary syndrome patients
Criteria

Inclusion Criteria:

  • Acute coronary syndrome

Exclusion Criteria:

  • Being on statin, having statin related side effects

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04069598


Locations
Layout table for location information
Turkey
Haseki Recruiting
Istanbul, Turkey
Contact: Umit Y Sinan    0212) 459 20 00    drumityasar@hotmail.com   
Siyami Ersek Recruiting
Istanbul, Turkey
Contact: Barış Güngör    +90(216) 542 44 44    barisgungor@gmail.com   
Tepecik Recruiting
Izmir, Turkey
Contact: Oner Ozdogan    +90 232 469 69 69    onerozdogan@yahoo.com   
Ozcan Basaran Recruiting
Mugla, Turkey, 48000
Contact: Ozcan Basaran    +905065359013    basaran_ozcan@yahoo.com   
Sponsors and Collaborators
Turkish Society of Cardiology
Layout table for additonal information
Responsible Party: Turkish Society of Cardiology
ClinicalTrials.gov Identifier: NCT04069598    
Other Study ID Numbers: A-HIT 4-SI Study
First Posted: August 28, 2019    Key Record Dates
Last Update Posted: September 12, 2019
Last Verified: September 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Myocardial Infarction
Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases